JADENU
Active Ingredient: DEFERASIROX
Product Overview
About JADENU
JADENU is a prescription medication containing the active ingredient Deferasirox, a chelating agent used to treat iron overload in patients with beta-thalassemia or other anemias who require regular blood transfusions.
Key Benefits & Uses
- Treatment of iron overload in patients with beta-thalassemia or other anemias requiring regular blood transfusions.
- Reduction of iron stores in the body to prevent complications associated with iron overload.
- Management of iron-related complications in patients with beta-thalassemia or other anemias.
Active Ingredient & Action
Deferasirox works by binding to iron in the body and promoting its excretion through the feces, thereby reducing iron stores and preventing complications associated with iron overload.
Important Notes
JADENU should only be used under the guidance of a healthcare professional. Patients with kidney disease or liver dysfunction should be closely monitored while taking JADENU. Common side effects may include diarrhea, nausea, and vomiting. It is essential to follow the recommended dosage and schedule to minimize the risk of adverse effects.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
